Gender- and androgen-related impact on the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary glands of mouse models of Sjögren's syndrome

Advances in Experimental Medicine and Biology

Volumn 438, Issue , 1998, Pages 447-452

  Toda, Ikuko ^a   Wickham, L Alexandra ^a   Rocha, Eduardo M ^a   Da Silveira, Lilia Aikawa ^a   Sullivan, David A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CLINICAL FEATURE; CONFERENCE PAPER; DRUG EFFECT; DRY EYE; FEMALE; GENE EXPRESSION REGULATION; HORMONAL THERAPY; LACRIMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; SALIVATION; SEX DIFFERENCE; SJOEGREN SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION; TARGET ORGAN; XEROSTOMIA;

ANDROGENS; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; LACRIMAL APPARATUS; MALE; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; SALIVARY GLANDS; SEX CHARACTERISTICS; SJOGREN'S SYNDROME; TESTOSTERONE;

ANIMALIA;

EID: 0031798911     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5359-5_62     Document Type: Article

References (25)

1. Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M, eds. Sjögren's Syndrome. State of the Art. Amsterdam: Kugler Press, 1994.
2. Lemp MA. Basic principles and classification of dry eye disorders. In: Lemp MA, Marquardt R, eds. The Dry Eye. Berlin: Springer-Verlag, 1992:101-131.
3. Sullivan DA, Wickham LA, Krenzer KL, Rocha EM, Toda I. Aqueous tear deficiency in Sjögren's syndrome: Possible causes and potential treatment. In: Pleyer U, Hartmann C and Sterry W, eds. Oculodermal Diseases - Immunology of Bullous Oculo-Muco-Cutaneous Disorders. Buren, The Netherlands: Aeolus Press, 1997:95-152.
4. Fox RI, Saito I. Sjögren's syndrome: immunologic and neuroendocrine mechanisms. Adv Exp Med Biol 1994; 350:609-621.
5. Ahmed SA, Talal N. Sex hormones and the immune system-part 2. Animal data. Bailliere's Clin Rheum 1990; 4:13-31.
6. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-317.
7. Chu JL, Drappa J, Parnassa A, Elkon K. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 1993; 178:723-730.
8. Mountz JD. Steinberg AD, Klinman DM, Smith HR, Mushinski JF. Autoimunity and increased c-myb transcription. Science 1984; 226:1087-1089.
9. Kitajima T, Furukawa F, Kanauchi H, Imamura S, Ogawa K, Sugiyama T. Histological detection of c-myb and c-myc proto-oncogene expression in infiltrating cells in cutaneous lupus erythematosus-like lesions of MRL/1 mice by in situ hybridization. Clin Immunol Immunopathol 1992; 62:119-123.
10. Sugai S, Saito I, Masaki Y, Takeshita S, Shimizu S, Tachibana J, Miyasaka N. Rearrangement of the rheumatoid factor-related germline gene Vg and bcl-2 expression in lymphoproliferative disorders in patients with Sjögren's Syndrome. Clin Immunol Immunopathol 1994; 72:181-186.
11. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by point mutation in the Fas ligand. Cell 1994; 76:969.
12. Sibbitt WL. Oncogenes, growth factors and autoimmune diseases. Antican Res 1991; 11:97-113.
13. Firestein GS. Cytokines in autoimmune diseases. Concepts Immunopathol 1992; 8:129-160.
14. Rocha EM, Toda I, Wickham, LA, Silveira LA, Sullivan DA. Effect of gender, androgens and cyclophosphamide on cytokine mRNA levels in lacrimal tissues of mouse models of Sjögren's syndrome. Submitted for publication, 1997.
15. Ono M, Rocha FJ, Sullivan DA. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-Ipr/lpr mouse model of Sjögren's syndrome. Exp. Eye Res. 1995; 61:659-666.
16. Rocha EM, Wickham LA, Huang Z, Toda I, Gao J, Silveira LA, Sullivan DA. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome. Adv Exp Med Biol 1997; in press.
17. Toda I, Rocha EM, Siveira LA, Wickham LA, Sullivan DA. Gender-related difference in the extent of lymphocyte infiltration in lacrimal and salivary glands of mouse models of Sjögren's syndrome. Submitted for publication, 1997.
18. Toda I, Wickham LA, Sullivan DA. Gender and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice. Submitted for publication, 1997.
19. Toda I, Wickham LA, Sullivan DA. Influence of gender and androgen treatment on the mRNA expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of the MRL/lpr mouse model of Sjögren's syndrome. Submitted for publication, 1997.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162:156-159.
21. Hoffman RW, Alspaugh MA, Waggie KS, Durham JB, Walker SE. Sjogren's syndrome in MRL/1 and MRL/n mice. Arthritis Rheum. 1984; 27:157-165.
22. Kessler HS. A laboratory model for Sjogren's syndrome. Am J Pathol 1968; 52:671-678.
23. Johnson BC, Morton JI, Trune DR. Lacrimal and salivary gland inflammation in the C3H/lpr autoimmune strain mouse: a potential mode for Sjögren's syndrome. Otolaryngol Head Neck Surg 1992; 106:394.
24. Moore PA, Bounous DI, Kaswan RL, Humphreys-Beher MG. Histologic examination of the NOD-mouse lacrimal glands, a potential model for idiopathic autoimmune dacryoadenitis in Sjogren's syndrome. Lab Anim Sci 1996; 46:125-128.
25. Toda I, Wickham LA, Rocha EM, Silveira LA, Sullivan DA. Identification of proto-oncogene and apoptotic factor mRNAs in human ocular surface tissues. Submitted for publication, 1997.